Navigation Links
Pharmos Corporation Reports 2008 Third Quarter Results
Date:11/6/2008

esearch and development expenses going forward.

A Phase 2a clinical trial with the Company's NanoEmulsion delivery technology for topical application of analgesic and anti-inflammatory agents commenced in June 2007 targeting 126 patients. Top line results are expected in the fourth quarter of 2008.

General and administrative expenses for the third quarter of 2008 decreased by 64%, from $1.2 million in 2007 to $0.4 million. The decline reflects decreases in virtually every general and administrative expense category. The primary reductions include a $468,000 reduction in payroll, a $93,000 reduction in consultant and professional fees and a $93,000 reduction in BOD fees. The decrease in payroll costs reflect the impact of the third and fourth quarter 2007 restructuring plans which have reduced the Company's head count from 51 employees in March 2007 to 11 employees at the end of September 2008. The decrease in consulting and professional fees in 2008 result from a decline in legal costs and investor relation costs, and a one time IRS section 382 tax analysis cost incurred in 2007. The decrease in the BOD meeting costs result from board members receiving Company common stock in lieu of cash payments.

For the first nine months ended September 30, 2008, Pharmos recorded a net loss of $9.1 million, or $0.35 per share compared to a net loss of $12.9 million, or $0.51 per share for the nine months ended September 30, 2007. Total operating expenses decreased 35% to $9.0 million from $13.7 million. Gross research and development expenses decreased 22% to $7.2 million from $9.3 million for the nine months ended September 30, 2007 primarily related to the Company's focus of cash resources on the Dextofisopam Phase 2b trial and the downsizing and curtailment of general research and development programs. Also a 66% decrease in general and administrative expenses to $1.7 million from $5.0 million due to the decrease in consulting and professional fees in 2008
'/>"/>

SOURCE Pharmos Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pharmos Restructures Operations in Israel
2. Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results
3. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
4. Brooke Franchise Corporation Announces Selected July Results
5. MedThink Communications Retained by NanoBio Corporation
6. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
7. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
11. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... (PRWEB) May 22, 2015 River Valley ... Kyle Johnson, the health system’s Chief Financial Officer (CFO), ... Johnson has served as the company CFO since 2011. ... will be joining the health system as CFO. Wesley ... interim basis, while the Board of Trustees conducts a ...
(Date:5/22/2015)... UK (PRWEB) May 22, 2015 ... leading treatment option for chronic obstructive pulmonary disorder ... GlaxoSmithKline plc and AstraZeneca plc as well as ... market share and position. But will market payers, ... the already well-entrenched products to completely new ones? ...
(Date:5/22/2015)... 22, 2015 Carnegie Science Center ... announced a new partnership to develop BodyTech, a dynamic, ... The initiative includes a new exhibit at the Science ... theater, and a new traveling science show, Anatomy Adventure, ... 2015. , Designed to explore a wide range ...
(Date:5/22/2015)... Power Systems is proud to announce the sponsorship ... Drobeck is in his second year of racing in the ... Missoula Fire Department in Missoula, MT. He entered the triathlon ... his career, he has had 15 1st Place finishes. In ... finishes in all seven of his 2014 races, including two ...
(Date:5/22/2015)... CA (PRWEB) May 22, 2015 ... Sunset Plaza Dental announces that they are now ... restorative and other dental treatments. At consultations, patients ... them. Questions regarding what certain treatments can achieve ... be covered during this initial appointment. If treatments ...
Breaking Medicine News(10 mins):Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2
... less-affluent families are at higher risk, study finds , TUESDAY, ... who have child care may suffer from a higher rate ... affluent families, new research suggests. , In the report, published ... Community Health , researchers looked at a study of 14,000 ...
... , TUESDAY, Nov. 24 (HealthDay News) -- Strains ... are increasingly showing up among hospital outpatients, raising ... research says. , From 1999 to 2006, researchers ... outpatients with methicillin-resistant Staphylococcus aureus (MRSA) ...
... ... the Academic and Research Communities , ... (PRWEB) -- Ziosoft®, Inc. a leader in advanced visualization and analysis ... the academic and research communities. The Windows®-based software can be used for reviewing ...
... ... with Stem Cell Therapy. , ... San Diego, CA (PRWEB) November 24, 2009 -- Entest Biomedical, Inc. (OTCBB: ENTB) ... a proprietary laser device which shall be owned by Entest and used in conjunction with ...
... ... doctors in providing proven, non-surgical relief to millions of sufferers. , ... Dallas, TX (PRWEB) November 24, 2009 ... Frozen Shoulder Syndrome Diagnosis & Treatment seminar dates today. The three-day training seminars ...
... ... American Podiatric Medical Association , ... Bethesda, Md. (Vocus) November 24, 2009 -- The average person walks between 8,000-10,000 steps a ... continue making their holiday travel plans, it’s easy to forget that the feet often bear ...
Cached Medicine News:Health News:MRSA Creeping Into Hospitals From the Outside 2Health News:MRSA Creeping Into Hospitals From the Outside 3Health News:Ziosoft Releases Free zioTerm Basic 2D/3D Software Application 2Health News:Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment 2Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 2Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 3Health News:Keep Holiday Travel Foot-Friendly 2Health News:Keep Holiday Travel Foot-Friendly 3
(Date:5/22/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ) ... to Prepare Application Dossiers for Oversea Medical device ... report to their offering. The ... market of the most growth potentiality, which is ... and producers to penetrate such market. It is ...
(Date:5/22/2015)... 22, 2015 Research and Markets ... the "Latest Regulations on Pharmaceutical International Multi-Center ... offering. This is first time in ... on international multi-center clinical trials of drugs in ... to be implemented on March 1, 2015. The ...
(Date:5/22/2015)... a sweeping analysis assessing the current state of diabetes ... conclude that there remains considerable room for improving treatment ... but especially for adolescents and young adults. The analysis ... the need to address barriers to care and implement ... patients achieve optimal metabolic control. The ...
Breaking Medicine Technology:China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 32015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
... Oct. 29 Amicus Therapeutics (Nasdaq: FOLD ... today, October 29, 2010 at 8:30 a.m. Eastern Time ... PLC to develop and commercialize Amigal (migalastat HCl) for ... and investors may access the conference call today at ...
... CHICAGO, Oct. 29 New data presented today at ... (EHMTIC) shows that persons with chronic migraine (headache on ... are much more likely to have annual household incomes ... < 15 days per month).  This difference in household ...
Cached Medicine Technology:Chronic Migraine Is Associated With Reduced Household Income and Greater Headache Impact 2Chronic Migraine Is Associated With Reduced Household Income and Greater Headache Impact 3
Inquire...
The essence of fluorescence analysis is sensitivity. The high throughput optical system in the RF-5301PC employs a blazed holographic grating, photomultiplier and digital signal processing to provide...
The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications....
... 200 is a fixed wavelength fluorometer ... nm emission. The spectral characteristics are ... double-stranded DNA using the standard Hoechst ... interference from the presence of protein, ...
Medicine Products: